用高剂量静脉注射硫胺治疗维尼克脑病:一个病例报告
Maria Alamir1, Ashley Cantu-Weinstein2, Rachel Branning3
1Ohio University Heritage College of Osteopathic Medicine, Cleveland, OH, USA.
Journal of addictive diseases
|July 1, 2024
概括
高剂量静脉注射的胺 (维生素B1) 有效地治疗了维尼克病.
科学领域:
- 神经学 神经学
- 营养神经科学 营养神经科学
背景情况:
- 韦尼克脑病 (Wernicke's encephalopathy,简称WE) 是一种严重的神经疾病,由胺缺乏引起.
- 对WE的最佳静脉入血胺剂量仍未得到充分研究.
- 酒精使用障碍 (AUD) 和营养不良是WE的常见风险因素.
研究的目的:
- 调查高剂量静脉注射硫胺在治疗维尼克脑病的疗效.
- 介绍一个案例研究,说明提氨酸剂量增加的影响.
主要方法:
- 一个病例报告,一个40岁的男性患有严重的AUD和营养不良,被诊断为WE.
- 静脉注射胺,最初是100毫克,然后增加到500毫克.
- 在剂量升级后症状缓解的临床观察.
主要成果:
- 最初的100毫克静脉注射西安胺并没有完全消除WE症状.
- 将剂量增加到500毫克的静脉滴氨酸导致精神状态改变和眼的快速改善.
- 在这种情况下,高剂量的IV硫胺证明了安全性和有效性.
结论:
- 高剂量静脉注射的胺 (>100毫克) 是维尼克脑病的安全有效的第一线治疗方法.
- 这种方法可以成功地管理神经和认知症状.
- 建议对WE诊断和治疗指南进行进一步的研究.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Pharmaceutical Poisoning: Treatment Strategies
279
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279
Hemorrhagic Stroke l: Introduction
20
A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
20
Transient Ischemic Attack l: Introduction
18
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
18
Encephalitis ll: Pathophysiology
22
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Hepatic Encephalopathy
53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)

